Rheumatol Ther 2020 Feb 01
Characteristics and Symptom Severity of Patients Reporting Systemic Lupus Erythematosus in the PatientsLikeMe Online Health Community: A Retrospective Observational Study.
Nyman E, Vaughan T, Desta B, Wang X, Barut V, Emmas C
Online health communities and research networks such as PatientsLikeMe (PLM) capture patient perspectives of diseases, including systemic lupus erythe ...
Read More
Source: PubMed
Clin. Rheumatol. 2020 Feb 01
The role of socioeconomic status in the susceptibility to develop systemic lupus erythematosus in Mexican patients.
Salgado-Galicia NA, Hernández-Doño S, Ruiz-Gómez D, Jakez-Ocampo J, Zúñiga J, Vargas-Alarcón G, Acuña V, Hernández MT, Márquez-García JE, García-Lechuga M, Llorente L, Lima G, Pineda C, Yu N, Yunis E, Granados J
Systemic lupus erythematosus (SLE) is an autoimmune inflammatory disorder for which Major Histocompatibility Complex (MHC) genes are well-identified a ...
Read More
Source: PubMed
J. Rheumatol.
Targetoid-like Lesions in the Setting of Systemic Lupus Erythematosus: A Case of Rowell Syndrome.
Ward JM, Hess JN, Davis LS
Read More
Source: PubMed
J. Rheumatol. 2020 Feb 01
Patterns of Health Care Utilization and Medication Adherence Among Youth with Systemic Lupus Erythematosus During Transfer from Pediatric to Adult Care.
Chang JC, Knight AM, Lawson EF
Youth with systemic lupus erythematosus (SLE) transferring from pediatric to adult care are at risk for poor outcomes. We describe patterns of rheumat ...
Read More
Source: PubMed
Int. Immunopharmacol.
Toll-like receptor 7 agonist imiquimod prevents the progression of SLE in MRL/lpr mice via inhibiting the differentiation of T follicular helper cells.
Duan X, Shen C, Zhang X, Wu L, Chen J, Ma B, Wang Q, Sun P, Lan Y, Su C
Previous research has recently indicated that TLR7 is able to induce CD4+T cell anergy, which is the opposite of the role it plays in innate immune ce ...
Read More
Source: PubMed